reduction of conjunctival bacterial flora with the use of mupirocin nasal ointment
DESCRIPTION
Reduction of Conjunctival Bacterial Flora with the Use of Mupirocin Nasal OintmentTRANSCRIPT
Reduction Of Conjunctival BacterialFlora With The Use Of
Mupirocin Nasal Ointment
Terry J. Alexandrou, MDOphthalmology Resident
The University of Chicago School of Medicine
Department of Ophthalmology and Visual Science
Acknowledgements
• Seenu Hariprasad
• William F. Mieler
• Joseph Benevento
• Anthony Mazzulla
• Michael Saidel
• Susan Ksiazek
• Kenneth Thompson
• Sue Boonlayangoor
• Grant Support:
— Research to Prevent Blindness Foundation
Post-Cataract Surgery Endophthalmitis
• 94.2% of isolates gram-positives
(70% S. epidermidis)
Han DP, et al. Am J Ophthalmol. 1996;122(1):1-17.
Endophthalmitis Vitrectomy Study
24%70%
6%
Gram-positivecoagulase-negative
organisms (Staphylococcusepidermidis)
Gram-negativeorganisms
OtherGram-positive
organisms
Sources of Bacterial Contamination
• Gram-positive organisms are part of human normal flora
— Eyelids
— Eyelashes
— Conjunctiva
— Nasal Secretions
• Speaker and colleagues found that organisms isolated from the vitreous were genetically indistinguishable from those recovered from the eyelids, conjunctiva, or nose in 14 of 17 cases of endophthalmitis
Mupirocin(Bactroban®, Glaxo-Smith Kline)
• Antibacterial agent produced by fermentation using the organism Pseudomonas fluorescens. Acts by interfering with the action of isoleucyl-transfer RNA synthetase
• Mupirocin is active against gram positive organisms, including Staphylococcus and Streptococcus spp.
• Available as a nasal ointment, and is used for the eradication of methicillin-resistant S. aureus.
• Nasal carriage of S. aureus was eliminated in 91% of colonized healthcare workers 2 to 4 days following treatment with mupirocin ointment.
Mupirocin (Bactroban®) Ointment (C26H43O9)2Ca●2H20
Reduction of Surgical Site InfectionsEffectiveness of using Mupirocin: Non-Ophthalmic Literature
• Nasal carriage of gram positive organisms is a well established risk factor for surgical site infections (SSI).
— In a large multicenter study of S. aureus bacteremia, greater than 80% of the blood isolates were identical to those from the anterior nares.
• Kluytmans and collegues demonstrated that perioperative elimination of nasal carriage using mupirocin reduced SSI rate in cardiothoracic surgery patients
• The “Mupirocin Study Group” demonstrated that using mupirocin nasal ointment effectively reduced the incidence of S. aureus infections in hemodialysis and peritoneal dialysis patients
Reduction of Surgical Site InfectionsEffectiveness of using Mupirocin
•Can use of Mupirocin ointment to eliminate nasal bacterial carriage prior to intraocular surgery be effective in reducing conjunctival bacterial flora?
Methods
• Prospective, blinded, randomized clinical trial
• 42 patients undergoing elective Phaco/IOL or PPV
— 22 patients were enrolled in the control group and received no nasal medication
— 20 patients were enrolled in the treatment group and were asked to self-administer mupirocin ointment to each nostril twice daily for 5 days prior to surgery
A) B) C)
MethodsCultures & Microbiology
• Nasal
— Obtained in all patients
— In treatment group, nasal cultures obtained prior to mupirocin administration.
• Conjunctival
— First before application of 5% povidone-iodine scrub
— Second immediately before surgery
— Care was taken to avoid touching the eyelid margin or lashes and patients did not received topical antibiotics prior to culture
• Microbiology
— Immediate innoculation on Columbia Agar with 5% Sheep Blood and Chocolate II Agar plates
— Plates were incubated overnight in 5-10% CO2
— Daily examination of plates until final report issued by blinded microbiologist
Results Nasal Cultures 100% Positive
9% S. Aureus (3 MRSA / 3 MSSA)
16% S. viridans
22% Corynebacterium 8% Others
45% Coag. Neg. Staph
Results Conjunctival Cultures
0%
5%
10%
15%
20%
25%
30%
35%
40%
45%
Before Povodine-Iodine Prep After Povodine-Iodine Prep
Control
Mupirocin
Discussion
• A significant reduction in conjunctival bacterial flora can be achieved with preoperative nasal application of mupirocin ointment
— Although the use of povidone-iodine is the “gold standard” for ocular surface sterilization, this reduction was observed with or without the use of povidone-iodine.
Discussion
• It has been proposed that nasal secretions may breach the sterile drape and contaminate the operative field*
• Kuhn and associates describe 2 cases of clear mucous nasal secretions reaccumulating on the conjunctiva during vitrectomy
• Studies underway to investigate this further
* Nagle F, Cooper RL. Nasal secretions in ocular surgery under general and local anesthesia. Ophthalmic Surg 1993;24:13-15.
Conclusions
• The goal of pre-operative prophylaxis of any type is to decrease the incidence of post-operative endophthalmitis
— Lower conjunctival contamination rates should theoretically reduce the incidence of postoperative endophthalmitis
• The use of mupirocin nasal ointment prior to intraocular surgery or intravitreal injections is a novel method for reducing conjunctival contamination rates
• Future studies will be needed to precisely define the role of mupirocin nasal ointment for the prophylaxis against intraocular infections
Thank you for your attention